© T. Pastinen

Tomi Pastinen is Associate Professor in the Department of Human Genetics at McGill University and Genome Quebec Innovation Centre. His research program is composed of a vibrant environment for human functional genomics applicable to complex disease trait studies. The components of this program include: a) genome-wide characterization of regulatory variation in human cells, b) human disease trait oriented population cell models, c) impact of perturbation on cis-regulatory variation, d) identification of causal and disease associated non-coding variants, e) functional epigenomics of pediatric cancers, and f) large-scale epigenome mapping. Dr. Pastinen has led two international large-scale projects: 1) Scientific Director of the GRiD (Gene Regulators in Disease) project funded by Genome Canada ($10M CDN over 5 years), and 2) McGill Epigenome Mapping Centre project funded by CIHR ($6M CDN over 5 years). He is currently an Associate Professor in the Department of Human Genetics at McGill University. He also serves as Scientific Officer for the CIHR Genetics panel and is board member of the International Human Epigenome Consortium (IHEC), the Canadian representative of the International Scientific Steering Committee (ISSC), and Chair of the IHEC Bioethics Workgroup.

© Uni. McGill
Mark Lathrop is Professor in the Department of Human Genetics at McGill University and Scientific Director of the McGill University and Genome Quebec Innovation Centre. Most recently, he was the scientific director of the Centre National de Genotypage (CNG), which he founded in 1998, and of the Fondation Jean Dausset Centre d’Étude du Polymorphism Humain (CEPH) in Paris, two of the major centers for large-scale biological research established by the French government. He was one of the founders of the CEPH, which pioneered international collaboration on the human genome in the 1980s-90s. Dr. Lathrop was the co-founder and first scientific director of the Wellcome Trust Centre for Human Genetics. Dr. Lathrop’s expertise is in genetics, genomics and statistics and he has also made major contributions to genetic approaches for the study of models of human disease in other mammalian species. His present scientific studies focus on using genetic and other high-throughput genomic approaches to identify DNA variants that predispose to common diseases, and to understand the effects of these in a biological and public health context. Dr. Lathrop is also visiting Professor of Human Genetics at the Institute of Medical Sciences at the University of Tokyo, chairs the Scientific Advisory Board for Japan’s Riken Center for Genomic Medicine, and is a member the Riken Scientific Council.

Updated on 07/03/2018

PASTINEN Tomi, PhD (contact PI) and LATHROP Mark, PhD

McGill Genome Center,
740, Av Dr Penfield, bureau 7104
Montréal (Québec) Canada; H3A 0G1

Contact by email